Sundia MediTech Overview
- Year Founded
-
2004

- Status
-
Acquired/Merged
- Employees
-
2,000

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
Sundia MediTech General Information
Description
Operator of a biotechnology pre-clinical contract research and manufacturing organization (CRMO). The company has built an integrated drug discovery and development platform from synthetic and medicinal chemistry, DMPK and in vitro/in vivo biology, process chemistry, formulation to analytical as well as API/starting material manufacturing of small molecules and it also offers services such as drug molecule design, screening, optimization, synthesis, chemical process research, molecular diagnostic services, pharmacology and more, to assist biotechnology companies and research institutes to accelerate innovation of medical drugs.
Contact Information
Website
www.sundia.comCorporate Office
- Building 8, Lane 388, Galileo Road
- Zhangjiang Hi-Tech Park, Pudong New Area
- Shanghai, 201203
- China
Corporate Office
- Building 8, Lane 388, Galileo Road
- Zhangjiang Hi-Tech Park, Pudong New Area
- Shanghai, 201203
- China
Sundia MediTech Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Sundia MediTech Comparisons
Industry
Financing
Details
Sundia MediTech Competitors (31)
One of Sundia MediTech’s 31 competitors is Resolian, a Private Equity-Backed company based in Malvern, PA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Resolian | Private Equity-Backed | Malvern, PA | ||||
Giant Med-Pharma Services | Venture Capital-Backed | Beijing, China | ||||
SARA Pharm Solutions | Corporation | Bucharest, Romania | ||||
Curia | Private Equity-Backed | Albany, NY | ||||
Aragen Life Sciences | Private Equity-Backed | Hyderabad, India |
Sundia MediTech Patents
Sundia MediTech Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-9434733-B2 | Pde9 inhibitors with imidazo triazinone backbone | Active | 26-Jan-2012 | ||
US-9533992-B2 | Pde9 inhibitors with imidazo triazinone backbone | Active | 26-Jan-2012 | ||
US-9850249-B2 | Pde9 inhibitors with imidazo triazinone backbone | Active | 26-Jan-2012 | ||
US-20160213674-A1 | Pde9 inhibitors with imidazo triazinone backbone | Active | 26-Jan-2012 | ||
US-20150045348-A1 | Pde9 inhibitors with imidazo triazinone backbone | Active | 26-Jan-2012 | C07D487/04 |
Sundia MediTech Signals
Sundia MediTech Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Sundia MediTech FAQs
-
When was Sundia MediTech founded?
Sundia MediTech was founded in 2004.
-
Where is Sundia MediTech headquartered?
Sundia MediTech is headquartered in Shanghai, China.
-
What is the size of Sundia MediTech?
Sundia MediTech has 2,000 total employees.
-
What industry is Sundia MediTech in?
Sundia MediTech’s primary industry is BPO/Outsource Services.
-
Is Sundia MediTech a private or public company?
Sundia MediTech is a Private company.
-
What is Sundia MediTech’s current revenue?
The current revenue for Sundia MediTech is
. -
How much funding has Sundia MediTech raised over time?
Sundia MediTech has raised $2.42M.
-
Who are Sundia MediTech’s investors?
Darwin Venture Management, IDG Capital, and UMC Capital have invested in Sundia MediTech.
-
Who are Sundia MediTech’s competitors?
Resolian, Giant Med-Pharma Services, SARA Pharm Solutions, Curia, and Aragen Life Sciences are some of the 31 competitors of Sundia MediTech.
-
When was Sundia MediTech acquired?
Sundia MediTech was acquired on 24-Sep-2020.
-
Who acquired Sundia MediTech?
Sundia MediTech was acquired by BioDuro-Sundia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »